Literature DB >> 155990

Use of laparoscopy to determine the microbiologic etiology of acute salpingitis.

R L Sweet, J Mills, K W Hadley, E Blumenstock, J Schachter, M O Robbie, D L Draper.   

Abstract

To determine the microbiologic etiology of acute salpingitis, laparoscopy was used in 26 patients to obtain specimens for a variety of microorganisms directly from the fallopian tube. Simultaneous culdocentesis was performed to obtain peritoneal fluid for microbiologic analysis. A variety of microorganisms were isolated from the fallopian tubes and cul-de-sac aspirate. However, the organisms isolated from the fallopian tube were not consistent with the cul-de-sac isolates. It appears that direct culture from the fallopian tube may be necessary to determine the microbiologic etiology and pathogenesis of acute salpingitis. N. gonorrhoeae was isolated from the cul-de-sac in 32 per cent of cases and the fallopian tube in 19 per cent. In patients with endocervical gonorrhea, the gonococcus was isolated from the fallopian tube in 38.5 per cent of cases. Aerobic and/or anaerobic bacteria were present in the cul-de-sac aspirate in 46 per cent of patients and in the fallopian tube in 38 per cent.

Entities:  

Keywords:  Age Factors; Biology; Blacks; Diseases; Endoscopy; Examinations And Diagnoses; Histology; Infections; Laboratory Examinations And Diagnoses; Laboratory Procedures; Laparoscopy; Parity; Pelvic Infections--etiology; Physical Examinations And Diagnoses; Treatment; Whites

Mesh:

Year:  1979        PMID: 155990     DOI: 10.1016/0002-9378(79)90798-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  18 in total

1.  Neonatal, urogenital isolates of biotype 4 nontypeable Haemophilus influenzae express a variant P6 outer membrane protein molecule.

Authors:  T F Murphy; C Kirkham; D J Sikkema
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics.

Authors:  Rebecca M Brotman; Emily J Erbelding; Roxanne M Jamshidi; Mark A Klebanoff; Jonathan M Zenilman; Khalil G Ghanem
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-08       Impact factor: 1.814

Review 3.  Pelvic inflammatory disease.

Authors:  J M Pearce
Journal:  BMJ       Date:  1990-04-28

4.  Typing of urogenital, maternal, and neonatal isolates of Haemophilus influenzae and Haemophilus parainfluenzae in correlation with clinical source of isolation and evidence for a genital specificity of H. influenzae biotype IV.

Authors:  R Quentin; J M Musser; M Mellouet; P Y Sizaret; R K Selander; A Goudeau
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

5.  Pelvic inflammatory disease.

Authors:  M J Hare
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-08

Review 6.  Optimum therapy for acute pelvic inflammatory disease.

Authors:  M G Dodson
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

Review 7.  Pelvic inflammatory disease: current concepts and treatment guidelines.

Authors:  P A Dale; P A Rice; K C Edelin
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

8.  Importance of Mycoplasma hominis in acute salpingitis assessed by culture and serological tests.

Authors:  K Lind; G B Kristensen; A C Bollerup; P Ladehoff; S Larsen; A Marushak; P Rasmussen; J Rolschau; I Skoven; T Sørensen
Journal:  Genitourin Med       Date:  1985-06

9.  Comparison of virulence markers of peritoneal and fallopian tube isolates with endocervical Neisseria gonorrhoeae isolates from women with acute salpingitis.

Authors:  D L Draper; J F James; G F Brooks; R L Sweet
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

10.  Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.

Authors:  H E Gnehm; S I Pelton; S Gulati; P A Rice
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.